The use of an impeded androgen—danazol—in the management of benign breast disorders
- 1 January 1977
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 127 (2) , 130-134
- https://doi.org/10.1016/s0002-9378(16)33237-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- BIOLOGICAL BASIS FOR MANAGEMENT OF BENIGN DISEASE OF THE BREASTPlastic and Reconstructive Surgery, 1975
- Malignant and benign human mammary disease: Estrogen binding in relation to clinical dataCancer, 1974
- Enovid therapy (norethynodrel with mestranol) for fibrocystic diseaseAmerican Journal of Obstetrics and Gynecology, 1973
- Carcinoma of the breast during estrogen replacement therapyCancer, 1972
- Clinical Studies with an Antigonadotropin-DanazolFertility and Sterility, 1971